StonvexLoading…
StonvexStonvexStonvexCore line items from MPX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $244.42M | $236.56M | $383.73M | $381.00M |
Operating Income | $14.03M | $18.27M | $49.20M | $51.80M |
Net Income | $11.38M | $17.85M | $41.70M | $40.35M |
EPS (Diluted) | $0.32 | $0.50 | $1.21 | $1.18 |
Total Assets | $147.23M | $171.25M | $193.80M | $163.72M |
Total Liabilities | $22.27M | $42.24M | $42.21M | $39.33M |
Cash & Equivalents | $43.51M | $52.38M | $71.95M | $43.17M |
Free Cash Flow OCF − CapEx | $14.92M | $24.93M | $46.67M | $46.85M |
Shares Outstanding | 35.00M | 34.71M | 34.47M | 34.22M |